Want to join the conversation?
Global insurance & annuity solutions provider $MET said that 4Q15 underwriting mainly in the US was less favorable than 4Q14 by $0.06 per share after adjusting for notable items in both periods. Property & Casualty, Corporate Benefit Funding and Retail Life are the primary drivers of the YoverY result.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.